n-methylaspartate has been researched along with Panic Attacks in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Coimbra, NC; de Fátima Dos Santos Sampaio, M; de Souza Crippa, JA; Dos Anjos-Garcia, T; Falconi-Sobrinho, LL; Khan, AU; Menescal-de-Oliveira, L | 1 |
| Almada, RC; Coimbra, NC; da Silva, JA; de Figueiredo, RM | 1 |
| Carpenter, A; Leyfer, O; Pincus, D | 1 |
| Aguiar, DC; Bastos, JR; Coimbra, CC; Costa, RB; Hott, SC; Mansur, FS; Moreira, FA; Resstel, LB; Viana, TG | 1 |
| Aguiar, DC; Hott, SC; Moreira, FA; Resstel, LB; Viana, TG | 1 |
| Aguiar, DC; Almeida-Santos, AF; Gobira, PH; Guimaraes, FS; Moreira, FA | 1 |
1 trial(s) available for n-methylaspartate and Panic Attacks
| Article | Year |
|---|---|
N-methyl-D-aspartate Partial Agonist Enhanced Intensive Cognitive-Behavioral Therapy of Panic Disorder in Adolescents.
Topics: Adolescent; Adult; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Double-Blind Method; Fear; Female; Humans; Implosive Therapy; Male; N-Methylaspartate; Panic Disorder; Parents; Psychotropic Drugs; Treatment Outcome | 2019 |
5 other study(ies) available for n-methylaspartate and Panic Attacks
| Article | Year |
|---|---|
Cannabidiol-induced panicolytic-like effects and fear-induced antinociception impairment: the role of the CB
Topics: Animals; Cannabidiol; Fear; Injections, Intraventricular; Male; N-Methylaspartate; Pain Measurement; Panic Disorder; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Ventromedial Hypothalamic Nucleus | 2020 |
Blockade of synaptic activity in the neostriatum and activation of striatal efferent pathways produce opposite effects on panic attack-like defensive behaviours evoked by GABAergic disinhibition in the deep layers of the superior colliculus.
Topics: Animals; Behavior, Animal; Cobalt; Corpus Striatum; Efferent Pathways; gamma-Aminobutyric Acid; Male; Motor Activity; N-Methylaspartate; Neural Inhibition; Neurotransmitter Agents; Panic Disorder; Rats, Wistar; Receptors, GABA-A; Superior Colliculi; Synaptic Transmission | 2018 |
Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks.
Topics: Animals; Arachidonic Acids; Benzamides; Biphenyl Compounds; Blood Pressure; Cannabinoids; Carbamates; Corticosterone; Dorsomedial Hypothalamic Nucleus; Endocannabinoids; Indoles; Male; Microinjections; N-Methylaspartate; Panic Disorder; Piperidines; Pyrazoles; Rats | 2019 |
Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
Topics: Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Behavior, Animal; Benzamides; Carbamates; Disease Models, Animal; Endocannabinoids; Enzyme Inhibitors; Male; N-Methylaspartate; Panic Disorder; Periaqueductal Gray; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1 | 2015 |
Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey.
Topics: Animals; Arachidonic Acids; Biphenyl Compounds; Cannabinoid Receptor Antagonists; Disease Models, Animal; Dose-Response Relationship, Drug; Endocannabinoids; Fluorescent Antibody Technique; Glycerides; Male; N-Methylaspartate; Panic Disorder; Periaqueductal Gray; Piperidines; Pyrazoles; Rats, Wistar; Receptor, Cannabinoid, CB1 | 2016 |